Atezolizumab for Carcinoma
This study is evaluating whether a combination of a vaccine and a drug can treat cancer.
See full descriptionAbout the trial for Carcinoma
Treatment Groups
This trial involves 2 different treatments. Atezolizumab is the primary treatment being studied. Participants will be divided into 2 treatment groups. There is no placebo group. The treatments being tested are in Phase 1 & 2 and have already been tested with other people.
About The Treatment
Eligibility
This trial is for patients born any sex aged 18 and older. You must have received 1 prior treatment for Carcinoma or one of the other 2 conditions listed above. There are 10 eligibility criteria to participate in this trial as listed below.
Approximate Timelines
Measurement Requirements
This trial is evaluating whether Atezolizumab will improve 3 primary outcomes and 5 secondary outcomes in patients with Carcinoma. Measurement will happen over the course of From baseline up to 90 days after last dose of study medication (up to approximately 2 years and 3 months).
Patient Q & A Section
Can carcinoma be cured?
Carcinoma cannot be cured. Some localized carcinoma may be cured if found and resected soon after it is diagnosed correctly, but most forms of the disease do not respond to treatment.
What is carcinoma?
The main objective of this article was to update the treatment of patients with cancer with respect to the diagnosis method used. Considering the differences found, it is probable that in the near future, a more effective and practical method will be utilized. In the near future, the more precise and accurate information on the patient's condition will be obtained from a variety of diagnostic tools as a basic need before administering treatment. In addition, the data regarding treatment will be based on the patients' own statements and will be obtained from patients who need to be under treatment. In conclusion, it is crucial to establish a standardized and rational method of treatment for cancer and to ensure that a standard system for diagnosing the disease among patients is in place.
How many people get carcinoma a year in the United States?
At a population level, the number of people diagnosed with primary cancer from 1979 thru 1995 in the US was approximately 1,600 per year. That is, approximately 1 in 2 patients with primary cancer in the US is diagnosed each year. If these patients develop additional cancers, the number may be higher. It is difficult to establish an unbiased estimate of the number of patients with cancer of any type that develops primary cancer in the US each year. Estimates of the number of newly diagnosed cancers and the burden of cancer can be derived from different sources.
What causes carcinoma?
Carcinomas show a diverse range of causation, with environmental factors influencing most cases and inherited predisposing genetic mutations affecting a small percentage of cases. The vast majority of cancer is caused by environmental toxicants. These are also the only factors to show an increased risk in a prospective cohort study. This is particularly true of breast and endometrial cancer. However, the link between environmental toxicity and causation is an emerging, controversial and evolving area.
What are the signs of carcinoma?
There are many signs related to carcinoma of the prostate. These can be divided into those seen in the clinical examination and those seen on MRI of the prostate, including PSA. Paediatric carcinoma has a particular pattern. The main symptoms include hematuria, dysuria, and a palpable lump in the prostate.\n
What are common treatments for carcinoma?
Most patients diagnosed with carcinoma receive chemotherapy in the adjuvant setting. Most patients diagnosed with carcinoma develop recurrent disease within the first year post resection. The majority of patients do not experience an adequate treatment response. Treatment is palliative in nature and most patients experience a brief, yet intense, dying experience.
What is the latest research for carcinoma?
There's a wide range of research topics, but one important idea that we all must remember is to never give up as a fight to treat and cure carcinoma. By remembering this common theme, this cancer will never go away.
What is the survival rate for carcinoma?
There is a high survival rate for carcinoma after surgery. The rate of recurrence, however, remains stable within the same time period despite many recurrences of carcinoma. In contrast, survival rate drops gradually after the time period of 5 years, which suggests that the quality of management improves as the patient ages.
What are the chances of developing carcinoma?
People taking aspirin have about 75% of the normal population risk of [colon cancer](https://www.withpower.com/clinical-trials/colon-cancer); a further 17% of people who take non-steroidal anti-inflammatory drugs have colon cancer. The majority of the people admitted to surgeons have some degree of inflammation and that seems to increase the chance of development of cancer. Cancer risks seem to increase with smoking, and people with the BRCA mutation. However, in the current study of this general population, the risks were much lower than those described from cancer data for people known to have the disease. It raises important questions about how general populations are being told about cancer risks in general, and about potential benefits and risk versus benefit in specific cases.
What is the average age someone gets carcinoma?
In the United States, the age of diagnosis for carcinoma is not decreasing. Results from a recent paper highlights the need for continuing efforts [to identify and treat the disease as early as possible in order to decrease the high mortality rate of people suffering from carcinoma disease (http://www.ohsu.edu/news/Pages/News_pages/Care_and_Cancer/Cancer_Basics.aspx)] as well as continued surveillance of new cases at increased frequency.
How serious can carcinoma be?
There is a considerable overlap in the symptoms of carcinoma and other serious medical conditions. Consequently, many people with cancer are initially misdiagnosed or fail to receive a correct diagnosis.
Does carcinoma run in families?
In a recent study, findings confirms a high prevalence of cancer in multiple families, and highlights the importance of performing tumour family history. We found no correlation between multiple family members' cases and the patients' familial history, suggesting that genetic predisposition has no role in this cancer in the majority of cases in this cohort.